sph7854
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 28, 2024 (NCT06483373)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Nuclear receptor ROR-gammaINHIBITOR
RORC inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06487455 | Phase 1 | Aug 6, 2024 | Shanghai Pharmaceuticals Holding Co., Ltd |
| NCT06483373 | Early Phase 1 (Phase 1) | May 28, 2024 | Shanghai Pharmaceuticals Holding Co., Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Pharmaceuticals Holding Co., Ltd | For profit | 2 | 2 | 1 | 2024 |
1 organizations
Page 1 / 1